Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-008410
Filing Date
2017-03-22
Accepted
2017-03-22 18:49:41
Documents
1
Period of Report
2017-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4158
  Complete submission text file 0000899243-17-008410.txt   5632
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VALERITAS, INC., 750 ROUTE 202 SOUTH SUITE 600 BRIDGEWATER NJ 08807
Business Address
Duke William E. (Reporting) CIK: 0001636135 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36199 | Film No.: 17707816